Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by BoredAccountGuyon Jan 23, 2021 4:05pm
343 Views
Post# 32368836

It's all about technical analysis

It's all about technical analysis
I starting buying into this stock around a month ago. The biggest reason for that, aside from the upcoming release of Aristotle, the increasing revenues, the reverse split, the potential for a Nasdaq listing, the significant discount compared to Grail, the renewed interest in Biopharma stocks, the recent interviews with the CEO on YouTube and many other reasons and upcoming catalysts, is the fact that technical analysis of the chart suggests this stock is going significantly higher. What do I see? I see an inverse head and shoulders pattern on the weekly chart, combined with a cup and handle, multiple bull flags, increasing bull volume, bullish MACD cross, a Golden cross, monthly higher lows, weekly higher lows and higher highs, a break and close above 1 dollar with a strong close at the high of the day, strong RSI readings, increasing volume and a coiled up triangle consolidation pattern on the monthly chart, the technical chart analysis of this stock is screaming buy
<< Previous
Bullboard Posts
Next >>